This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Feb;65(2):214-5.

doi: 10.1016/j.annemergmed.2014.12.020.

Are we there yet? Early stopping in clinical trials

Robert L Wears¹

Affiliations

Affiliation

¹ Department of Emergency Medicine, University of Florida, Jacksonville, FL; Clinical Safety Research Unit, Imperial College London, London, United Kingdom. Electronic address: wears@ufl.edu.

PMID: 25601251
DOI: 10.1016/j.annemergmed.2014.12.020

Editorial

Are we there yet? Early stopping in clinical trials

Robert L Wears. Ann Emerg Med. 2015 Feb.

. 2015 Feb;65(2):214-5.

doi: 10.1016/j.annemergmed.2014.12.020.

Author

Robert L Wears¹

Affiliation

¹ Department of Emergency Medicine, University of Florida, Jacksonville, FL; Clinical Safety Research Unit, Imperial College London, London, United Kingdom. Electronic address: wears@ufl.edu.

PMID: 25601251
DOI: 10.1016/j.annemergmed.2014.12.020

No abstract available

PubMed Disclaimer

Comment on

Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial.
Lewis LM, Graffeo C, Crosley P, Klausner HA, Clark CL, Frank A, Miner J, Iarrobino R, Chyung Y. Lewis LM, et al. Ann Emerg Med. 2015 Feb;65(2):204-13. doi: 10.1016/j.annemergmed.2014.07.014. Epub 2014 Aug 30. Ann Emerg Med. 2015. PMID: 25182544 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources